Immunocompatibility of bacteriophages as nanomedicines

Journal of Nanotechnology

Volumn , Issue , 2012, Pages

  Kaur, Tranum ^a   Nafissi, Nafiseh ^a   Wasfi, Olla ^a   Sheldon, Katlyn ^a   Wettig, Shawn ^a   Slavcev, Roderick ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; BACTERIAL STRAINS; EXPONENTIAL RATES; FILAMENTOUS PHAGE; GENETIC RESEARCH; HOST IMMUNE RESPONSE; HUMAN THERAPEUTICS; IMMUNOMODULATORY EFFECTS; MEDICAL RESEARCH; NANOMEDICINES; PHAGE THERAPY; TREATMENT MODALITY; VACCINE DEVELOPMENT;

ANTIBIOTICS; DIAGNOSIS; GENES; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; PATIENT MONITORING; PROTEINS;

BACTERIOPHAGES;

EID: 84861082304     PISSN: 16879503     EISSN: 16879511     Source Type: Journal    
DOI: 10.1155/2012/247427     Document Type: Review

References (105)

1. Twort F. W., Further investigations on the nature of ultra-microscopic viruses and their cultivation The Journal of Hygiene (London) 1936 36 204 235
2. d'Herelle F., Technique de la recherche du microbe filtrant bactériophage (Bacteriophagum intestinale) Comptes Rendus des Seances de la Societe de Biologie Paris 1918 81 1060 1062
3. d'Herelle F., Sur un microbe invisible antagoniste des bacilles dysentériques Comptes Rendus de l'Académie des Sciences Paris 1917 165 373 375
4. Clark J. R., March J. B., Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials Trends in Biotechnology 2006 24 5 212 218
5. Alisky J., Iczkowski K., Rapoport A., Troitsky N., Bacteriophages show promise as antimicrobial agents Journal of Infection 1998 36 1 5 15 (Pubitemid 128645619)
6. Carlton R. M., Phage therapy: past history and future prospects Archivum Immunologiae et Therapiae Experimentalis 1999 47 5 267 274
7. Smith T. L., Pearson M. L., Wilcox K. R., Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group The New England Journal of Medicine 1999 340 493 501
8. Taj Y., Abdullah F. E., Kazmi S. U., Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance Journal of the College of Physicians and Surgeons Pakistan 2010 20 11 728 732
9. Parisien A., Allain B., Zhang J., Mandeville R., Lan C. Q., Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides Journal of Applied Microbiology 2008 104 1 1 13 (Pubitemid 350265294)
10. Matsuzaki S., Rashel M., Uchiyama J., Sakurai S., Ujihara T., Kuroda M., Ikeuchi M., Tani T., Fujieda M., Wakiguchi H., Imai S., Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases Journal of Infection and Chemotherapy 2005 11 5 211 219 (Pubitemid 41570015)
11. Matsuzaki S., Yasuda M., Nishikawa H., Kuroda M., Ujihara T., Shuin T., Shen Y., Jin Z., Fujimoto S., Nasimuzzaman M. D., Wakiguchi H., Sugihara S., Sugiura T., Koda S., Muraoka A., Imai S., Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage MR11 Journal of Infectious Diseases 2003 187 4 613 624 (Pubitemid 36250025)
12. Szczaurska-Nowak K., Dabrowska K., Celka M., Kurzepa A., Nevozhay D., Wietrzyk J., witaa-Jele K., Syper D., Poniak G., Opolski A., Grski A., Radzikowski C., Antitumor effect of combined treatment of mice with cytostatic agents and bacteriophage T4 Anticancer Research 2009 29 6 2361 2370
13. Levin B. R., Bull J. J., Population and evolutionary dynamics of phage therapy Nature Reviews Microbiology 2004 2 2 166 173 (Pubitemid 39490070)
14. Weber-Dabrowska B., Zimecki M., Mulczyk M., Effective phage therapy is associated with normalization of cytokine production by blood cell cultures Archivum Immunologiae et Therapiae Experimentalis 2000 48 1 31 37
15. Wang T., Dsouza G. G., Bedi D., Fagbohun O. A., Potturi L. P., Papahadjopoulos-Sternberg B., Petrenko V. A., Torchilin V. P., Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein Nanomedicine 2010 5 4 563 574
16. Sarikaya M., Tamerler C., Jen A. K. Y., Schulten K., Baneyx F., Molecular biomimetics: nanotechnology through biology Nature Materials 2003 2 9 577 585
17. Sergeeva A., Kolonin M. G., Molldrem J. J., Pasqualini R., Arap W., Display technologies: application for the discovery of drug and gene delivery agents Advanced Drug Delivery Reviews 2006 58 15 1622 1654 (Pubitemid 44830148)
18. Mori T., Cancer-specific ligands identified from screening of peptide-display libraries Current Pharmaceutical Design 2004 10 19 2335 2343 (Pubitemid 38855040)
19. Krumpe L. R. H., Mori T., The use of phage-displayed peptide libraries to develop tumor-targeting drugs International Journal of Peptide Research and Therapeutics 2006 12 1 79 91
20. Bedi D., Musacchio T., Fagbohun O. A., Gillespie J. W., Deinnocentes P., Bird R. C., Bookbinder L., Torchilin V. P., Petrenko V. A., Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes Nanomedicine 2011 7 3 315 323
21. Nicol C. G., Denby L., Lopez-Franco O., Masson R., Halliday C. A., Nicklin S. A., Kritz A., Work L. M., Baker A. H., Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature FEBS Letters 2009 583 12 2100 2107
22. Kurzepa A., Dabrowska K., Skaradziski G., Grski A., Bacteriophage interactions with phagocytes and their potential significance in experimental therapy Clinical and Experimental Medicine 2009 9 2 93 100
23. Clark J. R., March J. B., Bacterial viruses as human vaccines? Expert Review of Vaccines 2004 3 4 463 476 (Pubitemid 39061711)
24. Clark J. R., March J. B., Bacteriophage-mediated nucleic acid immunisation FEMS Immunology and Medical Microbiology 2004 40 1 21 26 (Pubitemid 38083354)
25. March J. B., Clark J. R., Jepson C. D., Genetic immunisation against hepatitis B using whole bacteriophage particles Vaccine 2004 22 13-14 1666 1671 (Pubitemid 38447214)
26. Dabrowska K., Opolski A., Wietrzyk J., Switala-Jelen K., Godlewska J., Boratynski J., Syper D., Weber-Dabrowska B., Gorski A., Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models Anticancer Research 2004 24 6 3991 3995 (Pubitemid 40468698)
27. Pajtasz-Piasecka E., Rossowska J., Du D., Weber-Dabrowska B., Zabocka A., Grski A., Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma Immunology Letters 2008 116 1 24 32
28. Fortuna W., Midzybrodzki R., Weber-Dabrowska B., Grski A., Bacteriophage therapy in children: facts and prospects Medical Science Monitor 2008 14 8 RA126 RA132
29. Molenaar T. J. M., Michon I., de Haas S. A. M., Van Berkel T. J. C., Kuiper J., Biessen E. A. L., Uptake and processing of modified bacteriophage M13 in mice: implications for phage display Virology 2002 293 1 182 191
30. de Almeida S. S., Magalhes A. A. C., Soares S. C., Zurita-Turk M., Goulart L. R., Miyoshi A., Azevedo V., The phage display technique: advantages and recent patents Recent Patents on DNA and Gene Sequences 2011 5 2 136 148
31. Kurzepa A., Dabrowska K., Skaradziski G., Grski A., Bacteriophage interactions with phagocytes and their potential significance in experimental therapy Clinical and Experimental Medicine 2009 9 2 93 100
32. Bloch H., Experimental investigation on the relationships between bacteriophages and malignant tumors Archives of Virology 1940 1 481 496
33. Kantoch M., Mordarski M., Binding of bacterial viruses by tumor cells in vitro Postpy Higieny i Medycyny Dowiadczalnej 1958 12 2 191 192
34. Dabrowska K., Opolski A., Wietrzyk J., Switala-Jelen K., Boratynski J., Nasulewicz A., Lipinska L., Chybicka A., Kujawa M., Zabel M., Dolinska-Krajewska B., Piasecki E., Weber-Dabrowska B., Rybka J., Salwa J., Wojdat E., Nowaczyk M., Gorski A., Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of 3 integrin signaling pathway Acta Virologica 2004 48 4 241 248 (Pubitemid 47434295)
35. Dabrowska K., Opolski A., Wietrzyk J., Activity of bacteriophages in murine tumor models depends on the route of phage administration Oncology Research 2005 15 4 183 187 (Pubitemid 41176503)
36. Dabrowska K., Zembala M., Boratynski J., Switala-Jelen K., Wietrzyk J., Opolski A., Szczaurska K., Kujawa M., Godlewska J., Gorski A., Hoc protein regulates the biological effects of T4 phage in mammals Archives of Microbiology 2007 187 6 489 498 (Pubitemid 46800698)
37. Ohtsuki T., Tsuda H., Morimoto C., Good or evil: CD26 and HIV infection Journal of Dermatological Science 2000 22 3 152 160 (Pubitemid 30068660)
38. Eriksson F., Tsagozis P., Lundberg K., Parsa R., Mangsbo S. M., Persson M. A. A., Harris R. A., Pisa P., Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages Journal of Immunology 2009 182 5 3105 3111
39. Nishikawa M., Reactive oxygen species in tumor metastasis Cancer Letters 2008 266 1 53 59
40. Nishikawa M., Hashida M., Takakura Y., Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis Advanced Drug Delivery Reviews 2009 61 4 319 326
41. Przerwa A., Zimecki M., witaa-Jele K., Dabrowska K., Krawczyk E., uczak M., Weber-Dabrowska B., Syper D., Midzybrodzki R., Grski A., Effects of bacteriophages on free radical production and phagocytic functions Medical Microbiology and Immunology 2006 195 3 143 150 (Pubitemid 44421174)
42. Miedzybrodzki R., Switala-Jelen K., Fortuna W., Weber-Dabrowska B., Przerwa A., Lusiak-Szelachowska M., Dabrowska K., Kurzepa A., Boratynski J., Syper D., Pozniak G., Lugowski C., Gorski A., Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes Virus Research 2008 131 2 233 242 (Pubitemid 351173394)
43. Weber-Dabrowska B., Mulczyk M., Gorski A., Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man Transplantation Proceedings 2003 35 4 1385 1386 (Pubitemid 36765538)
44. Victor V. M., Rocha M., Esplugues J. V., De la Fuente M., Role of free radicals in sepsis: antioxidant therapy Current Pharmaceutical Design 2005 11 24 3141 3158 (Pubitemid 41149930)
45. Gill J. J., Hollyer T., Sabour P. M., Bacteriophages and phage-derived products as antibacterial therapeutics Expert Opinion on Therapeutic Patents 2007 17 11 1341 1350 (Pubitemid 350186589)
46. Becker S. C., Foster-Frey J., Stodola A. J., Anacker D., Donovan D. M., Differentially conserved staphylococcal SH3b5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain Gene 2009 443 1-2 32 41
47. Loessner M. J., Schneider A., Scherer S., Modified Listeria bacteriophage lysin genes (ply) allow efficient overexpression and one-step purification of biochemically active fusion proteins Applied and Environmental Microbiology 1996 62 8 3057 3060
48. Varea J., Monterroso B., Siz J. L., Lpez-Zumel C., Garca J. L., Laynez J., Garca P., Menéndez M., Structural and thermodynamic characterization of Pal, a phage natural chimeric lysin active against pneumococci The Journal of Biological Chemistry 2004 279 42 43697 43707 (Pubitemid 39390674)
49. Nelson D., Schuch R., Chahales P., Zhu S., Fischetti V. A., PlyC: a multimeric bacteriophage lysin Proceedings of the National Academy of Sciences of the United States of America 2006 103 28 10765 10770 (Pubitemid 44078050)
50. O'Flaherty S., Ross R. P., Meaney W., Fitzgerald G. F., Elbreki M. F., Coffey A., Potential of the Polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals Applied and Environmental Microbiology 2005 71 4 1836 1842 (Pubitemid 40546101)
51. Filatova L. Y., Becker S. C., Donovan D. M., Gladilin A. K., Klyachko N. L., LysK, the enzyme lysing Staphylococcus aureus cells: specific kinetic features and approaches towards stabilization Biochimie 2010 92 5 507 513
52. Daniel A., Euler C., Collin M., Chahales P., Gorelick K. J., Fischetti V. A., Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus Antimicrobial Agents and Chemotherapy 2010 54 4 1603 1612
53. Pastagia M., Euler C., Chahales P., Fuentes-Duculan J., Krueger J. G., Fischetti V. A., A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains Antimicrobial Agents and Chemotherapy 2011 55 2 738 744
54. Fenton M., Ross R. P., Mcauliffe O., O'Mahony J., Coffey A., Characterization of the staphylococcal bacteriophage lysin CHAP K Journal of Applied Microbiology 2011 111 4 1025 1035
55. Letarov A., Kulikov E., The bacteriophages in human- and animal body-associated microbial communities Journal of Applied Microbiology 2009 107 1 1 13
56. Gill S. R., Pop M., DeBoy R. T., Eckburg P. B., Turnbaugh P. J., Samuel B. S., Gordon J. I., Relman D. A., Fraser-Liggett C. M., Nelson K. E., Metagenomic analysis of the human distal gut microbiome Science 2006 312 5778 1355 1359 (Pubitemid 43839542)
57. Sonnenburg J. L., Angenent L. T., Gordon J. I., Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nature Immunology 2004 5 6 569 573 (Pubitemid 38811880)
58. Srivastava A. S., Kaido T., Carrier E., Immunological factors that affect the in vivo fate of T7 phage in the mouse Journal of Virological Methods 2004 115 1 99 104 (Pubitemid 37500968)
59. Shacklett B. L., Anton P. A., HIV infection and gut mucosal immune function: updates on pathogenesis with implications for management and intervention Current Infectious Disease Reports 2010 12 1 19 27
60. Payne R. J. H., Jansen V. A. A., Pharmacokinetic principles of bacteriophage therapy Clinical Pharmacokinetics 2003 42 4 315 325 (Pubitemid 36433874)
61. Dabrowska K., Switaa-Jelen K., Opolski A., Weber-Dabrowska B., Gorski A., A review: bacteriophage penetration in vertebrates Journal of Applied Microbiology 2005 98 1 7 13 (Pubitemid 40139261)
62. Ochs H. D., Davis S. D., Wedgwood R. J., Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases Journal of Clinical Investigation 1971 50 12 2559 2568
63. Yacoby I., Bar H., Benhar I., Targeted drug-carrying bacteriophages as antibacterial nanomedicines Antimicrobial Agents and Chemotherapy 2007 51 6 2156 2163 (Pubitemid 46903108)
64. Moghimi S. M., Hunter A. C., Murray J. C., Nanomedicine: current status and future prospects FASEB Journal 2005 19 3 311 330 (Pubitemid 40316520)
65. Pajtasz-Piasecka E., Rossowska J., Du D., Weber-Dabrowska B., Zabocka A., Grski A., Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma Immunology Letters 2008 116 1 24 32
66. Grski A., Wazna E., Dabrowska B. W., Dabrowska K., witaa-Jele K., Midzybrodzki R., Bacteriophage translocation FEMS Immunology and Medical Microbiology 2006 46 3 313 319
67. An H., Qian C., Cao X., Regulation of Toll-like receptor signaling in the innate immunity Science China Life Sciences 2010 53 1 34 43
68. Diacovich L., Gorvel J. P., Bacterial manipulation of innate immunity to promote infection Nature Reviews Microbiology 2010 8 2 117 128
69. Ostuni R., Zanoni I., Granucci F., Deciphering the complexity of Toll-like receptor signaling Cellular and Molecular Life Sciences 2011 67 24 4109 4134
70. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S., Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide evidence for TLR4 as the Lps gene product Journal of Immunology 1999 162 7 3749 3752 (Pubitemid 29314747)
71. Yang R. B., Mark M. R., Gray A., Huang A., Xie M. H., Zhang M., Goddard A., Wood W. I., Gurney A. L., Godowski P. J., Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling Nature 1998 395 6699 284 288 (Pubitemid 28447554)
72. Bauer S., Kirschning C. J., Hcker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G. B., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition Proceedings of the National Academy of Sciences of the United States of America 2001 98 16 9237 9242 (Pubitemid 32743900)
73. Rubinstein A., Mizrachi Y., Bernstein L., Shliozberg J., Golodner M., Liu G. Q., Ochs H. D., Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage X174 in asymptomatic HIV-1 infected patients AIDS 2000 14 4 F55 F62
74. Elkins K. L., Rhinehart-Jones T. R., Stibitz S., Conover J. S., Klinman D. M., Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria Journal of Immunology 1999 162 4 2291 2298 (Pubitemid 29288853)
75. Heeg K., Zimmermann S., CpG DNA as a Th1 trigger International Archives of Allergy and Immunology 2000 121 2 87 97 (Pubitemid 30130780)
76. Krieg A. M., The role of CpG motifs in innate immunity Current Opinion in Immunology 2000 12 1 35 43 (Pubitemid 30093448)
77. Geier M. R., Trigg M. E., Merril C. R., Fate of bacteriophage lambda in non immune germ free mice Nature 1973 246 5430 221 223
78. Merril C. R., Biswas B., Carlton R., Jensen N. C., Creed G. J., Zullo S., Adhya S., Long-circulating bacteriophage as antibacterial agents Proceedings of the National Academy of Sciences of the United States of America 1996 93 8 3188 3192 (Pubitemid 26125592)
79. Inchley C. J., The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage Clinical and Experimental Immunology 1969 5 1 173 187
80. Inchley C. J., Howard J. G., The immunogenicity of phagocytosed T4 bacteriophage: cell replacement studies with splenectomized and irradiated mice Clinical and Experimental Immunology 1969 5 1 189 198
81. Uhr J. W., Weissman G., Intracellular distribution and degradation of bacteriophage in mammalian tissues The Journal of Immunology 1965 94 544 550
82. Nelstrop A. E., Taylor G., Collard P., Studies on phagocytosis. II. In vitro phagocytosis by macrophages Immunology 1968 14 3 339 346
83. Merril C. R., Scholl D., Adhya S. L., The prospect for bacteriophage therapy in Western medicine Nature Reviews Drug Discovery 2003 2 6 489 497 (Pubitemid 37361729)
84. Cuesta A. M., Suarez E., Larsen M., Jensen K. B., Sanz L., Compte M., Kristensen P., varez-Vallina L., Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I Immunology 2006 117 4 502 506
85. Barfoot R., Denham S., Gyure L. A., Hall J. G., Hobbs S. M., Jackson L. E., Robertson D., Some properties of dendritic macrophages from peripheral lymph Immunology 1989 68 2 233 239 (Pubitemid 19246567)
86. Sokoloff A. V., Bock I., Zhang G., Sebestyén M. G., Wolff J. A., The interactions of peptides with the innate immune system studied with use of T7 phage peptide display Molecular Therapy 2000 2 2 131 139
87. Miedzybrodzki R., Fortuna W., Weber-Dabrowska B., Gorski A., A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses Clinical and Experimental Medicine 2009 9 4 303 312
88. Kim K. P., Cha J. D., Jang E. H., Klumpp J., Hagens S., Hardt W. D., Lee K. Y., Loessner M. J., PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response Microbial Biotechnology 2008 1 3 247 257
89. Croyle M. A., Chirmule N., Zhang Y., Wilson J. M., PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver Human Gene Therapy 2002 13 15 1887 1900 (Pubitemid 35292683)
90. Zhang J., Xiao X., Liu W., Demirci G., Li X. C., Inhibitory receptors of the immune system: functions and therapeutic implications Cellular and Molecular Immunology 2009 6 6 407 414
91. Carroll M. C., The complement system in regulation of adaptive immunity Nature Immunology 2004 5 10 981 986 (Pubitemid 41057714)
92. Fearon D. T., The complement system and adaptive immunity Seminars in Immunology 1998 10 5 355 361 (Pubitemid 28499549)
93. Janssen B. J. C., Gros P., Structural insights into the central complement component C3 Molecular Immunology 2007 44 13 3 10 (Pubitemid 44754839)
94. Wedgwood R. J., Ochs H. D., Davis S. D., The recognition and classification of immunodeficiency diseases with bacteriophage phiX 174 Birth Defects 1975 11 1 331 338
95. Ochs H. D., Buckley R. H., Kobayashi R. H., Kobayashi A. L., Sorensen R. U., Douglas S. D., Hamilton B. L., Hershfield M. S., Antibody responses to bacteriophage X174 in patients with adenosine deaminase deficiency Blood 1992 80 5 1163 1171
96. Seyama K., Nonoyama S., Gangsaas I., Hollenbaugh D., Pabst H. F., Aruffo A., Ochs H. D., Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome Blood 1998 92 7 2421 2434 (Pubitemid 28452985)
97. Nonoyama S., Etzioni A., Toru H., Ruggerie D. P., Lewis D., Pollack S., Aruffo A., Yata J. I., Ochs H. D., Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency European Journal of Immunology 1998 28 2 589 598 (Pubitemid 28101736)
98. Bernstein L. J., Ochs H. D., Wedgwood R. J., Rubinstein A., Defective humoral immunity in pediatric acquired immune deficiency syndrome Journal of Pediatrics 1985 107 3 352 357 (Pubitemid 15240786)
99. Ochs H. D., Junker A. K., Collier A. C., Virant F. S., Handsfield H. H., Wedgwood R. J., Abnormal antibody responses in patients with persistent generalized lymphadenopathy Journal of Clinical Immunology 1988 8 1 57 63 (Pubitemid 18066783)
100. Cohen I. R., Norins L. C., Antibiodies of the IgG, IgM, and IgA classes in newborn and adult sera reactive with gram-negative bacteria Journal of Clinical Investigation 1968 47 5 1053 1062
101. Fogelman I., Davey V., Ochs H. D., Elashoff M., Feinberg M. B., Mican J., Siegel J. P., Sneller M., Lane H. C., Evaluation of CD4+ T cell function in vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization Journal of Infectious Diseases 2000 182 2 435 441 (Pubitemid 30651039)
102. Shearer W. T., Lugg D. J., Rosenblatt H. M., Nickolls P. M., Sharp R. M., Reuben J. M., Ochs H. D., Antibody responses to bacteriophage X-174 in human subjects exposed to the Antarctic winter-over model of spaceflight Journal of Allergy and Clinical Immunology 2001 107 1 160 164 (Pubitemid 32105260)
103. Hedstrom S. A., Kamme C., Antibodies against staphylococcal bacteriophages in human sera. II. Assay of antibodies in exacerbation and regression of chronic staphylococcal osteomyelitis Acta Pathologica et Microbiologica ScandinavicaSection B 1973 81 6 749 752
104. Kamme C., Antibodies against staphylococcal bacteriophages in human sera. I. Assay of antibodies in healthy individuals and in patients with staphylococcal infections Acta Pathologica et Microbiologica ScandinavicaSection B 1973 81 6 741 748
105. Synnott A., Ohshima K., Nakai Y., Tanji Y., IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages Biotechnology Progress 2009 25 2 552 558